Premium
Excess Productivity Costs of Systemic Lupus Erythematosus, Systemic Sclerosis, and Sjögren's Syndrome: A General Population–Based Study
Author(s) -
McCormick Natalie,
Marra Carlo A.,
Sadatsafavi Mohsen,
Kopec Jacek A.,
AviñaZubieta J. Antonio
Publication year - 2019
Publication title -
arthritis care and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.032
H-Index - 163
eISSN - 2151-4658
pISSN - 2151-464X
DOI - 10.1002/acr.23573
Subject(s) - medicine , presenteeism , absenteeism , population , productivity , sick leave , demography , physical therapy , environmental health , management , sociology , economics , macroeconomics
Objective To determine excess productivity losses and costs of systemic lupus erythematosus ( SLE ), systemic sclerosis ( SS c), and Sjögren's syndrome ( SS ) at the population level. Methods Administrative databases from the province of British Columbia, Canada, were used to establish population‐based cohorts of SLE , SS c, and SS , and matched comparison cohorts were selected from the general population. Random samples from these cohorts were surveyed about time absent from paid and unpaid work and working at reduced levels/efficiency (presenteeism), using validated labor questionnaires. We estimated excess productivity losses and costs of each diagnosis (over and above nonsystemic autoimmune rheumatic diseases [non‐ SARD s]), using 2‐part models and work disability rates (not employed due to health). Results Surveys were completed by 167 SLE , 42 SS c, and 90 SS patients, and by 375 non‐ SARD s (comparison group) participants. Altogether, predicted excess hours of paid and unpaid work loss were 3.5, 3.2, and 3.4 hours per week for SLE , SS c, and SS patients, respectively. Excess costs were $86, $69, and $84 (calculated as 2015 Canadian dollars) per week, or $4,494, $3,582, and $4,357 per person annually, respectively. Costs for productivity losses from paid work stemmed mainly from presenteeism ( SLE = 69% of costs, SS c = 67%, SS = 64%, and non‐ SARD s = 53%), not from absenteeism. However, many working‐age patients were not employed at all, due to health ( SLE = 36%, SS c = 32%, SS = 30%, and non‐ SARD s = 18%), and the majority of total productivity costs were from unpaid work loss ( SLE = 73% of costs, SS c = 74%, SS = 60%, and non‐ SARD s = 47%). Adjusted excess costs from these unpaid production losses were $127, $100, and $82 per week, respectively, among SLE , SS c, and SS patients. Conclusion In this population‐based sample of prevalent SLE , SS c, and SS , lost productivity costs were substantial, mainly from presenteeism and unpaid work impairments.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom